These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 12901135)
41. Molecular genetics of RH and its clinical application. Flegel WA Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832 [TBL] [Abstract][Full Text] [Related]
42. Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study. Seltsam A; Wagner F; Lambert M; Bullock T; Thornton N; Scharberg EA; Grueger D; Schneeweiss C; Blasczyk R Transfusion; 2014 Jul; 54(7):1823-30. PubMed ID: 24635443 [TBL] [Abstract][Full Text] [Related]
43. [Molecular biology advance in the Rh blood group system]. Sun ZG; Ding M; Wang BJ Fa Yi Xue Za Zhi; 2005 Feb; 21(1):65-7. PubMed ID: 15895812 [TBL] [Abstract][Full Text] [Related]
44. Blood group antibodies and their significance in transfusion medicine. Poole J; Daniels G Transfus Med Rev; 2007 Jan; 21(1):58-71. PubMed ID: 17174221 [TBL] [Abstract][Full Text] [Related]
45. [ABO blood group and subtype]. Kitamura K Nihon Rinsho; 2005 Jul; 63 Suppl 7():667-9. PubMed ID: 16111363 [No Abstract] [Full Text] [Related]
46. Current issues in blood transfusion for sickle cell disease. Wahl S; Quirolo KC Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238 [TBL] [Abstract][Full Text] [Related]
47. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn]. Miquel E; Cavelier B; Bonneau JC; Rouger P Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293 [TBL] [Abstract][Full Text] [Related]
51. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation. Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013 [TBL] [Abstract][Full Text] [Related]
52. Blood and component therapy. Woods ME; Mazza I Nurs Clin North Am; 1980 Sep; 15(3):629-46. PubMed ID: 6905083 [No Abstract] [Full Text] [Related]
53. [Identification of antibodies and selection of blood for transfusion]. Dokić M; Radojcić M Bilt Hematol Transfuz; 1981; 9(1-3):101-3. PubMed ID: 7349749 [TBL] [Abstract][Full Text] [Related]
55. Does hybridoma technology still have a place in transfusion medicine? Yuan FF; Watt JM; Geczy AF Transfus Med Rev; 2002 Jul; 16(3):230-8. PubMed ID: 12075560 [TBL] [Abstract][Full Text] [Related]
56. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation. Mueller MM; Seifried E Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864 [TBL] [Abstract][Full Text] [Related]
57. [Antibody elution from red blood cells]. Kitamura K Nihon Rinsho; 2005 Jul; 63 Suppl 7():722-3. PubMed ID: 16111380 [No Abstract] [Full Text] [Related]
58. Blood groups of primates: historical perspective and synopsis. Moor-Jankowski J J Med Primatol; 1993 Jan; 22(1):1-2. PubMed ID: 8411094 [No Abstract] [Full Text] [Related]
59. Mass-scale red cell genotyping of blood donors. Denomme GA; Johnson ST; Pietz BC Transfus Apher Sci; 2011 Feb; 44(1):93-9. PubMed ID: 21292556 [TBL] [Abstract][Full Text] [Related]
60. Transfusion in the age of molecular diagnostics. Reid ME Hematology Am Soc Hematol Educ Program; 2009; ():171-7. PubMed ID: 20008196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]